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Abstract
Cellular restriction factors, which render cells intrinsically resistant to viruses, potentially impose genetic barriers to cross-
species transmission and emergence of viral pathogens in nature. One such factor is APOBEC3G. To overcome APOBEC3G-
mediated restriction, many lentiviruses encode Vif, a protein that targets APOBEC3G for degradation. As with many
restriction factor genes, primate APOBEC3G displays strong signatures of positive selection. This is interpreted as evidence
that the primate APOBEC3G locus reflects a long-term evolutionary ‘‘arms-race’’ between retroviruses and their primate
hosts. Here, we provide direct evidence that APOBEC3G has functioned as a barrier to cross-species transmission, selecting
for viral resistance during emergence of the AIDS-causing pathogen SIVmac in captive colonies of Asian macaques in the
1970s. Specifically, we found that rhesus macaques have multiple, functionally distinct APOBEC3G alleles, and that
emergence of SIVmac and simian AIDS required adaptation of the virus to evade APOBEC3G-mediated restriction. Our
evidence includes the first comparative analysis of APOBEC3G polymorphism and function in both a reservoir and recipient
host species (sooty mangabeys and rhesus macaques, respectively), and identification of adaptations unique to Vif proteins
of the SIVmac lineage that specifically antagonize rhesus APOBEC3G alleles. By demonstrating that interspecies variation in
a known restriction factor selected for viral counter-adaptations in the context of a documented case of cross-species
transmission, our results lend strong support to the evolutionary ‘‘arms-race’’ hypothesis. Importantly, our study confirms
that APOBEC3G divergence can be a critical determinant of interspecies transmission and emergence of primate lentiviruses,
including viruses with the potential to infect and spread in human populations.
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Introduction
In addition to the human immunodeficiency viruses (HIV-1 M,
N, O and P and HIV-2 A–H), there are more than forty
lentiviruses endemic to African old world primates [1,2]. The
distribution of these viruses among modern primates is consistent
with a complex history of cross-species transmissions between
different host lineages [2,3]. Well-documented examples include
the emergence of both HIV-1 and HIV-2 in humans in the mid-
to-late 20th century, and emergence of pathogenic SIVmac in
captive Asian macaques in the 1970s [2,4,5,6,7,8]. The exact time
and circumstances under which SIVsm initially jumped from sooty
mangabeys into rhesus macaques to give rise to SIVmac are
unknown, but it is very likely that transmission may have resulted
from experimental interventions involving the transfusion of
material from one species into another [9]. Despite the extraor-
dinary attention the primate lentiviruses have since received from
the AIDS research community, very little is known about the
impact of host genetic variation on the transmission of these
viruses between different primate species, or the degree to which
successful emergence of lentiviral pathogens requires adaptation to
overcome genetic divergence between reservoir species and newly
emergent hosts.
Cellular restriction factors are host factors that render the host
cell resistant to viral infection (also referred to as intrinsic
immunity) [10,11]. For many restriction factor genes, the rate of
fixation of nonsynonymous changes often exceeds that expected by
genetic drift alone, consistent with evolution under strong positive
selection, and it is generally assumed that viral pathogens are the
source of selective pressure driving evolution of such genes
[12,13,14]. As a consequence of positive selection, even phyloge-
netically similar species are likely to differ in terms of restriction
factor functionality. Thus, interspecies differences in restriction
factor loci could serve as genetic barriers to cross-species
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transmission and emergence of viruses. One way to test this
hypothesis is to focus on known transmission events and ask
whether specific restrictions played a role. Viruses that successfully
overcome species-level barriers imposed by restriction should
harbor adaptive changes (relative to viruses in the established host)
that confer resistance to restriction in the new host. Thus,
identification of changes which correlate with host-switching
events, and which demonstrably overcome restriction(s) imposed
by the new host, constitute direct evidence that a specific host
restriction factor can act as determinant of cross-species transmis-
sion and emergence of viral pathogens. For example, we
previously reported that the host restriction factor TRIM5 can
suppress viral replication in vivo, exerting selective pressure during
the initial stages of cross-species transmission [15]. More
specifically, we demonstrated that allelic variation in TRIM5
influences the outcome of SIVsm infection in rhesus macaques,
and that emergence of SIVsm (as pathogenic SIVmac) required
adaptations to overcome the genetic barrier imposed by the most
common variant of rhesus macaque TRIM5.
The cellular restriction factor APOBEC3G (apolipoprotein B
mRNA-editing enzyme catalytic polypeptide-like 3G) inhibits
retroviruses by incorporating into budding virions and inducing
hypermutation of the viral cDNA during reverse transcription
[16,17,18]. APOBEC3G (A3G) is one of seven members of the
APOBEC3 gene cluster found in primates [19,20]. A3G is
expressed in hematopoietic cell populations, including T cells
and myeloid cells, all of which are targets for lentiviral infection
[21]. Most lentiviruses counter the antiviral activity of A3G by
means of an accessory protein called Vif (viral infectivity factor).
Vif functions by bridging A3G proteins with a cellular E3
ubiquitin ligase complex, thus marking A3G for proteasomal
degradation [22]. Typically, the interaction between A3G
homologs and the Vif proteins of different lentiviruses are
species-specific, indicative of Vif-specific adaptation to A3G of
the native host [23,24,25].
The emergence of SIVmac, and subsequent outbreaks of AIDS
in captive macaque colonies in the 1970s, was a striking parallel to
the emergence of HIV and outbreaks of AIDS in humans around
the same time [5,26,27]. To examine the importance of A3G as a
determinant of cross-species transmission and emergence of
primate lentiviruses, we asked whether A3G-mediated restriction
influenced the successful transmission of SIVsm from its native
host, the sooty mangabey (Cercocebus atys), into colonies of Asian
rhesus macaques (Macaca mulatta). We found that the A3G coding
sequences of sooty mangabeys and rhesus macaques have several
fixed, nonsynonymous differences. Moreover, we found that
rhesus A3G (rhA3G) has an unusual polymorphism in the N-
terminal domain, in which a highly conserved tyrosine is replaced
by a two-amino acid insertion (either Y59/LR59–60 or Y59/LL59–60).
Structural modeling of the insertion indicates that it is in spatial
proximity to residue 128, a previously identified determinant of
human and African green monkey A3G sensitivity to the Vif
proteins of HIV-1 and SIVagm [24,28,29]. The model suggests that
these two positions (60 and 128) may define a common Vif-
interaction surface on A3G that is exploited by lentiviral Vif
proteins.
While we found that Vif from SIVsm can degrade the more
ancestral rhA3GY allele, it was unable to induce degradation of
rhA3GLR. In contrast, we found that the Vif proteins of multiple,
independent SIVmac isolates induced degradation of all three
rhesus alleles (rhA3GLR, rhA3GLL and rhA3GY). Furthermore, we
identified a single 17Gly-to-17Glu adaptation common to the Vif
proteins of multiple SIVmac isolates that confers the ability to
degrade rhA3GLR and rhA3GLL. This same adaptation occurred
at least twice, once during emergence of SIVmac, and again
during intentional adaptation of SIVsm to rhesus macaques by
experimental passage in vivo (SIVsmE543) [30]. Convergent
evolution, at a specific Vif residue in at least two independent
pathogenic SIVmac viruses, clearly indicates that A3G influenced
the emergence of pathogenic SIV and simian AIDS in U.S.
macaques. Thus, our results demonstrate that APOBEC3G-
mediated restriction initially served as an active barrier to full
emergence of SIVsm (as SIVmac) in rhesus macaques, selecting for
adaptations rendering the virus insensitive to restriction (and
therefore better adapted to the macaque host).
Results
Allelic variation in rhesus macaque and sooty mangabey
A3G
To investigate the possible role of A3G as a genetic barrier to
transmission of SIVsm from its natural host into rhesus macaques,
we first surveyed cDNA samples from multiple individual sooty
mangabeys and rhesus macaques for polymorphisms in the A3G
coding sequence. We identified seven nonsynonymous single-
nucleotide polymorphisms (nsSNPs) in rhesus macaque A3G
(rhA3G) and four nsSNPs in sooty mangabey A3G (smA3G)
(Figure 1A, see also Figure S1). Changes were only chosen when
they were detected in at least three independent clones. With one
exception (144D/G), the nsSNPs clustered either in the first active
domain or the second pseudoactive domain of A3G. In addition to
single amino-acid substitutions (59Y/L, 73Q/H/R, 77E/K,
144D/G, 353C/R and 356 C/R), rhesus macaques also have
an insertion at position 60 (L or R). The four substitutions in sooty
mangabeys included two in the first active domain (76L/R and
111K/E) and two in the second pseudoactive domain (370D/A
and 376R/Q). It is notable that polymorphisms in both species are
clustered in the same two regions of the protein, and that almost
all substitutions in both regions resulted in a difference in charge
Author Summary
APOBEC3G is a host factor that can inhibit replication of
primate lentiviruses, including HIV-1, HIV-2, and the related
simian immunodeficiency viruses (SIVs) of African prima-
tes. As a consequence, primate lentiviruses encode a
protein, called Vif, which can induce degradation of
APOBEC3G. Given its antiviral role, APOBEC3G may be an
important genetic barrier to interspecies jumping of
primate lentiviruses. To study this possibility, we asked
whether APOBEC3G affected transmission of SIV from
sooty mangabeys (SIVsm) to rhesus macaques and
subsequent emergence of pathogenic SIVmac in the
1970s. We found that APOBEC3G of sooty mangabeys
and rhesus macaques have divergent protein sequences,
and that the Vif proteins of SIVsm (Vif-SIVsm) cannot
counteract rhesus macaque APOBEC3G. We mapped Vif-
SIVsm resistance to a specific substitution in the N-terminal
domain of rhesus APOBEC3G, in which a highly conserved
tyrosine is replaced by leucine-arginine (YRLR). We also
identified a viral counter-adaptation, found in the Vif
proteins of all SIVmac strains, which specifically confers the
ability to antagonize APOBEC3G of rhesus macaques. This
change was most likely selected during adaptation of SIV
to its new host. Together, these results demonstrate that
APOBEC3G can serve as a critical genetic determinant of
interspecies transmission of primate immunodeficiency
viruses.
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(either a charge switch or gain/loss of a charge). It is striking that
polymorphism at some of these sites occur in multiple species; for
example, one of the polymorphic sites found in rhesus macaque
(residue 77) and one found in sooty mangabey (residue 110) are
both polymorphic in African green monkeys [31]. Similarly,
position 130 is polymorphic in both rhesus macaques (either
asparagine or aspartic acid) and African green monkeys (either
aspartic acid or histidine) [32]. The clustering of nonsynonymous
polymorphisms in the first active domain, including polymor-
phisms at sites that are polymorphic in more than one species, is
Figure 1. Rhesus macaque and sooty mangabey A3G coding sequences are highly polymorphic and differ in sensitivity to Vif-
mediated degradation. (A) Shown are nonsynonymous polymorphisms found in cDNA samples from sooty mangabeys (alleles numbered sm1-
sm6) and rhesus macaques (alleles numbered rh1-rh6) and their relative distribution across the A3G protein. Sooty mangabey polymorphisms are
indicated with orange boxes, rhesus macaque polymorphisms with green boxes. The numbers indicate the position of the amino acid in the protein
and the letters indicate the amino acids found at that position. (B) Rhesus macaque and sooty mangabey A3G allele containing plasmids were co-
transfected with plasmids expressing Vif-SIVsmE041, Vif-SIVmac239, or an empty vector (no Vif) control (indicated as ‘‘control’’). The ability of Vif
proteins to induce A3G degradation is reflected by a reduced or absent A3G band relative to controls. Anti-b-actin served as a protein loading control.
See also Figures S1, S2 and S3.
doi:10.1371/journal.ppat.1003641.g001
APOBEC3G and Emergence of Pathogenic SIV
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consistent with a region undergoing extensive, adaptive evolution
in response to positive selection. We sought to determine whether
any of these variants had functional consequences with respect to
restriction of SIVsm and SIVmac.
Multiple rhesus macaque A3G alleles resist degradation
by Vif-SIVsm
We tested all of the rhesus macaque A3G alleles (rh1-rh6) and
sooty mangabey A3G alleles (sm1-sm6) for incorporation into
SIVmac239DVif virions and for the ability to restrict SIV-
mac239DVif (Figure S2). We found that all twelve alleles (six
sooty mangabey and six rhesus macaque) are incorporated into
budding virions in the absence of Vif, and all twelve were able to
restrict infectivity. Thus, the differences in protein sequence that
distinguish the alleles do not result in substantial defects in overall
A3G function.
We then asked whether variation in rhesus macaque APO-
BEC3G results in differences in resistance or sensitivity to
degradation by lentiviral Vif proteins. Specifically, we tested the
Vif proteins of two viruses, a primary sooty mangabey isolate
(SIVsmE041) and a pathogenic, macaque-adapted isolate (SIV-
mac239), for the ability to induce degradation of each of the
rhA3G alleles (Figure 1B). Of the six different rhA3G alleles tested,
only one (allele rh6) was clearly sensitive to degradation by Vif-
SIVsmE041, although one other allele (rh2) was weakly sensitive to
degradation in the presence of Vif-SIVsmE041. In contrast, all six
rhesus macaque alleles (rh1-rh6) were clearly degraded by Vif-
SIVmac239. Both Vif-SIVsmE041 and Vif-SIVmac239 induced
degradation of all six sooty mangabey A3G alleles (Figure 1B and
Figure S3).
LR59–60 renders A3G resistant to Vif-SIVsmE041 induced
degradation and is unique to macaques
All of the rhesus A3G alleles that resist Vif-SIVsmE041-
mediated degradation have a Tyr-to-Leu substitution at position
59, followed by either an Arg insertion (alleles rh1, rh3, rh4, and
rh5), or a Leu insertion (allele rh2). In contrast, the rh6 allele and
all six of the sooty mangabey alleles retain a highly conserved Tyr
at position 59, and lack any additional insertions. Importantly, the
Y/LR and Y/LL substitutions are the only differences that
distinguish all of the Vif-SIVsmE041-resistant A3G proteins from
all of the sensitive alleles, leading us to hypothesize that these
substitution are responsible for the observed differences in
sensitivity to degradation by Vif-SIVsmE041. To test this
hypothesis, we used site-directed mutagenesis to change one of
the resistant alleles (rh1) at position 59/60, either substituting the
Arg for an Leu (LRR LL) or removing the insertion and reverting
position 59 to the ancestral/conserved Tyr (LR R Y). Both
mutations (R60L and LR59/60Y) rendered rhA3G sensitive to
Vif-SIVsmE041 degradation, but did not alter sensitivity to Vif-
SIVmac239-mediated degradation (Figure 2A).
Notably, the tyrosine at position 59 is highly conserved, and is
found at the homologous position in most other primate A3G
proteins, whereas the additional insertions (LR and LL) are unique
to Asian macaques (Figure 2B). We therefore generated A3G
expression constructs representing three additional primate
species, including pigtail macaque (Macaca nemestrina), African
green monkey (Clorocebus aethiops) and human (Homo sapiens), and
tested these for sensitivity or resistance to degradation by Vif-
SIVsmE041 and Vif-SIVmac239 (Figure 2C). All three A3G
orthologs retain the ancestrally conserved Tyr59, and in accor-
dance with our earlier observations, all three of these were
degraded by expression of Vif-SIVsmE041 and Vif-SIVmac239.
Finally, we asked whether the Y/LR substitution had a direct
effect on the Vif-A3G interaction, using co-immunoprecipitation
(Figure 2D). We compared binding of rhA3GLR and rhA3GY to
both Vif-SIVmac239 and Vif-SIVsmE041. While Vif-SIVmac239
bound equally well to both rhA3GLR and rhA3GY, there was a
dramatic reduction in binding of Vif-SIVsmE041 to rhA3GLR
relative to rhA3GY. This result suggests that the Y/LR substitution
exerts a direct effect on the Vif-A3G interaction.
Position 130 can influence sensitivity of rhA3GLR to
Vif-SIVsmE041
Compton and Emerman previously described a N/D polymor-
phism at position 130 in rhA3G [32]. Out of 219 rhesus macaques
that we screened, almost half carried an asparagine at position 130
(animals with the 130N/N or 130N/D genotypes) (Figure S4B),
and alleles rh1-rh6 all have an asparagine at position 130.
Strikingly, of 72 animals that were homozygous for the 60LR allele
(LR/LR genotype), only three had an aspartic acid at position 130
(LR/LR + N/D genotype) (Figure S4C). There were no LR/LR +
D/D homozygous animals. In contrast, 69 animals were of the
60LR/LR 130N/N genotype (95.8%). Thus, despite the high
frequency of both 60LR and 130D, the combined 60LR+130D
haplotype was present at very low frequency (Figure S4C).
Because the 60LR + 130D haplotype appears to be rare in our
cohort, we decided to test the functional consequences of the
residue at position 130 in the context of alleles differing at position
59/60. To do this, we constructed a series of double mutants by
site directed mutagenesis (Figure S4A). We found that rhA3GLR,
rhA3GLL and rhA3GY remained sensitive to Vif-SIVmac239
regardless of the presence of an asparagine or aspartic acid at
position 130. Likewise, degradation of rhA3GLL and rhA3GY by
Vif-SIVsmE041 was also unaffected by the substitution at position
130. Surprisingly, however, introduction of an asparagine at
position 130 rendered rhA3GLR sensitive to degradation by Vif-
SIVsmE041. Given the rarity of the 60LR+130D haplotype, it is
tempting to speculate that the low frequency of this allele reflects
the history of SIV outbreaks in captive macaque colonies.
However, proving or disproving this possibility is complicated by
the use of selective breeding procedures in U.S. primate research
centers and a current lack of information regarding allele
frequencies in natural macaque populations.
Frequency of rhA3GLR in rhesus macaques
To determine the respective frequencies of the rhA3GLR,
rhA3GLL and rhA3GY alleles, we used archived genomic DNA
samples to genotype 219 captive-bred rhesus macaques (Table 1).
The allelic frequency of rhA3GLR was an impressive 48.9%,
followed by rhA3GY (24.7%) and rhA3GLL (26.5%). Likewise,
homozygote genotype frequencies were the lowest for rhA3GY/Y
and rhA3GLL/LL (8.7% and 14.6%, respectively) and highest for
rhA3GLR/LR (32.9%). Using BLAST and sequence alignments, we
identified the presence of the LR insertion in at least one
additional species of Asian macaques, Macaca fasicularis (crab-
eating macaque) (see also [33]). We confirmed this finding by
genotyping genomic DNA from 17 crab-eating macaques, and
found that this species also harbors the Y/LR polymorphism at
positions 59–60 (genotype frequencies in this small sampling were:
23% LR/LR; 42% Y/Y; 35% Y/LR). Thus, the A3GLR allele
likely dates back at least as far as the common ancestor of rhesus
macaques and crab-eating macaques, giving a minimum age of
approximately 1.2–2.5 million years ago [34]. So far, all other
primate A3G sequences in the public sequence databases have the
ancestral Tyr at position 59, except for Colobinae spp. which have a
Ser at that position [32]. Interestingly, Compton and Emerman
APOBEC3G and Emergence of Pathogenic SIV
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also describe a three amino-acid insertion in Colobinae A3G four
residues downstream (positions 64–66) that affects sensitivity to
degradation by Vif from SIVagm.Sab in tissue culture.
Amino acid 17 in the N-terminal half of Vif governs the
interaction with rhA3GLR
We next sought to identify adaptations in Vif-SIVmac239 that
conferred the ability to degrade rhA3GLR. Previous studies
reported that sequences in the N-terminal part of Vif proteins
are important for determining the species-specificity of Vif
interactions with A3G [35,36,37,38]. Because there are multiple
differences in the N-terminal regions of the Vif-SIVsmE041 and
Vif-SIVmac239 proteins, we first constructed a chimeric Vif
protein in which the N-terminal 56 residues of Vif-SIVsmE041
were replaced with the homologous portion of Vif-SIVmac239
(Figure 3A). As with Vif-SIVmac239, expression of the chimeric
Vif protein was also able to induce degradation of all three rhA3G
alleles (Figure 3B), indicating that adaptative changes to overcome
rhA3G-mediated restriction might be found within the first 56
amino acids of the Vif protein.
Figure 2. A Tyr to Leu-Arg substitution at position 59/60 makes rhA3G resistant to Vif-SIVsmE041 induced degradation. (A) Site-
directed mutagenesis was used to mutate a resistant rhesus macaque allele (rh1) to either one of two naturally occurring sensitive alleles (rhA3GLL,
rhA3GY), their ability to resist Vif-mediated degradation was visualized by western blot. We used an empty vector control to test expression in the
absence of Vif (indicated as ‘‘control’’). Anti-b-actin served as a protein loading control. (B) Partial alignment of A3G proteins from different species
(rh1, rh2, rh6 = rhesus macaque alleles; pigtail = pigtail macaque, sooty = sooty mangabey, AGM = African green monkey). Also indicated is the
observed sensitivity of the A3Gs (listed as ‘‘not degraded’’ or ‘‘degraded’’) to either Vif-SIVsmE041 or Vif-SIVmac239 induced degradation. (C)
Immunoblot showing activity of Vif-SIVsmE041, Vif-SIVmac239 and an empty vector (no Vif) control against A3G proteins from African green monkey
(Haplotype 1 see [31]), pigtail macaque and human. Equal expression levels were confirmed using anti-b-actin as a loading control. (D) Co-
immunoprecipitation experiment with Vif-SIVmac239 and Vif-SIVsmE041 and rhA3GLR, rhA3GY or a no A3G control. Whole-cell lysates were analyzed
by immunoblotting using antibodies specific for FLAG (Vif), HA (A3G) or GAPDH (loading control). The immunoprecipitations (IP) were analyzed with
antibodies specific for FLAG (Vif) or HA (A3G).
doi:10.1371/journal.ppat.1003641.g002
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We tested a series of additional Vif proteins derived from SIV
isolates of several different host species, including rhesus macaque-,
pig-tailed macaque-, cynomolgus macaque- and sooty mangabey-
derived isolates. These included Vif from SIVsmE543, a virus
isolated after experimental passage of SIVsm through two rhesus
macaques [27,30]; Vif from SIVmac142, which was isolated from a
rhesus macaque infected unintentionally in utero [39]; Vif from
SIVmne027, which was isolated from a pig-tailed macaque [27];
and Vif from SIVmfa186, a virus isolated from the lymph node of
an SIV+ cynomolgus macaque (in vivo passage history unknown)
[40,41]. All four SIV Vifs (Vif-SIVsmE543, Vif-SIVmac142, Vif-
SIVmne and SIVmfa186) were able to induce degradation of all
three rhA3G variants (Figure 3C). In contrast, and as shown
previously, Vif-SIVsmE041 tested in parallel induced degradation
of rhA3GY and rhA3GLL, but not of rhA3GLR.
To rule out the possibility that Vif-SIVsmE041 is unique
among SIVsm viruses, we also tested the Vif protein of a second
primary SIVsm isolate (SIVsmCFU212, GenBank Accesssion
#JX860407) [42], as well as the Vif proteins of two SIVsm
isolates that were each derived by infection of single pig-tailed
macaques with primary SIVsm (SIVsmPBj and SIVsm-PG) [27]
[43]. As with Vif-SIVsmE041, the Vif-SIVsmCFU212, Vif-
SIVsmPBj and Vif-SIVsmPG proteins all failed to induce
degradation of rhA3GLR but were able to induce degradation
of rhA3GY (Figure S6).
By inspecting an alignment of the first 56 amino acids of
Vif from multiple SIVmac and SIVsm isolates, we identified
two residues (positions 17 and 21) that were conserved amongst
all SIVmac strains and SIVsmE543 yet differed from the Vif
proteins of SIVsm viruses (Figure 3D and Figure S5). We there-
fore substituted the individual residues at positions 17 and 21
in Vif-SIVmac239 with the corresponding residues of Vif-
SIVsmE041, thereby changing the negatively-charged glutamic
acid to an uncharged glycine (E17G) or the positively-charged
arginine to a positively charged lysine (R21K), and asked
whether either substitution had an effect on the ability of Vif-
SIVmac239 to degrade rhA3GLR. We tested both mutants for
the ability to induce degradation of rhA3GLR, rhA3GLL and
rhA3GY by co-transfection (Figure 4A). Expression of mutant
Table 1. Rhesus macaque APOBEC3G genotype frequencies.
Genotype
Number of Animals
(n=219) Frequencies %
Y/Y 19 8.7
LL/LL 32 14.6
LR/LR 72 32.9
Y/LL 26 11.9
Y/LR 44 20
LL/LR 26 11.9
doi:10.1371/journal.ppat.1003641.t001
Figure 3. The determinant in Vif for interaction with rhA3GLR lies within the first 56 amino acids of the Vif protein. (A) Cartoon of a
chimeric protein containing the first 56 amino acids of Vif-SIVmac239 and the rest of Vif-SIVsmE041. (B) Immunoblot showing activity of the parental
Vif proteins (Vif-SIVsmE041 and Vif-SIVmac239), the Vif-Chimera and an empty vector (no Vif) control against the three different rhA3G alleles
(rhA3GLR, rhA3GLL and rhA3GY). Anti-b-actin served as a protein loading control. (C) Immunoblot showing activity of six Vif proteins and an empty
vector (no Vif) control against the three rhA3G alleles (rhA3GLR, rhA3GLL and rhA3GY). Anti-b-actin served as a protein loading control. (D) Partial
alignment of the NTD of the Vif protein from six different SIV strains as indicated. Highlighted in red are amino acids 17 and 21 which are conserved
amongst Vif proteins from macaque derived SIV strains but differ in Vif from SIVsmE041. See also Figure S5.
doi:10.1371/journal.ppat.1003641.g003
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Vif-SIVmac239(E17G), in which the negatively charged amino
acid was changed to an uncharged amino acid, failed to induce
degradation of rhA3GLR, but was nonetheless functionally intact,
as evidenced by the ability to degrade both the rhA3GLL and
rhA3GY proteins.
We also altered the Vif of rhesus-macaque isolate SIVsmE543
at the same position, again changing the glutamic acid to a glycine,
and tested the mutant against the three rhA3G alleles and a sooty
mangabey allele (Figure 4B). As with Vif-SIVmac, as a
consequence of changing this one amino acid, the Vif-SIVsmE543
protein was unable to induce degradation of rhA3GLR, yet
retained the ability to induce degradation of rhA3GLL, rhA3GY
and smA3G.
To confirm that this loss of Vif function (the ability to degrade
A3G) was due to the amino acid at position 17, we also performed
the converse experiment, altering Vif-SIVsmE041 by mutation of
residue 17 from a glycine to a glutamic acid, and testing the
mutant against the three rhA3G alleles (Figure 4B). We observed
that the Vif-SIVsmE041(G17E) mutant gained the ability to
degrade the rhA3GLR allele, while also retaining the ability to
induce degradation of the other two rhA3G alleles (as well as sooty
mangabey A3G).
To further confirm the importance of the residue at position 17,
we looked at additional Vif sequences from multiple, pre-
viously described SIVsm strains [42] (including SIVsmCFU212,
SIVsmPBj and SIVsm-PG) and found that they all had a glycine
at position 17 (Figure S5 and Figure S6). Likewise, HIV-2 Vif and
Vif-SIVstm (an SIV from stump tailed macaques, or Macaca
arctoides), both of which represent independent cross-species
transmissions originating from SIVsm, also have a glycine at
position 17. Thus, Gly17 is well conserved among SIVsm
lineages, whereas Glu17 is very likely to have been evolutionarily
derived in conjunction with emergence of SIVmac in rhesus
macaques, and independently during experimental adaptation of
SIVsmE543 to rhesus macaques. This observation, coupled with
our experimental results, strongly suggests that the G17E
substitution found in viruses of the SIVmac lineage represents
adaptation to overcome the interspecies genetic barrier imposed
by rhA3GLR alleles.
The Vif-SIVmac239(E17G) mutation results in increased
incorporation of rhA3GLR into virions and lower
infectivity
We next tested the effects of Vif-SIVsmE041, Vif-SIVmac239
and the Vif-SIVmac239(E17G) mutant in an infectivity assay. To
this end, we trans-complemented an SIVmac239 Vif deletion
mutant (SIVmac239DVif) by co-expression of Vif-SIVsmE041,
Vif-SIVmac239 or the Vif-SIVmac239(E17G) mutant, and asked
whether these rescued viral infectivity in the presence of different
rhA3G alleles. Specifically, complementation with the Vif-
SIVmac239(E17G) mutant or with Vif-SIVsmE041 resulted in
reduced infectivity relative to virus complemented with wild type
Vif-SIVmac239 in the presence of rhA3GLR (p-value,0.0001
for both Vif-SIVmac239(E17G) vs. Vif-SIVmac239 and Vif-
SIVsmE041 vs. Vif-SIVmac239). There was no significant differ-
ence between the Vif-SIVmac239(E17G) and Vif-SIVsmE041
complemented viruses, relative to rhA3GLR (Figure 5A). In contrast,
both proteins were nearly as effective as wild type Vif-SIVmac239 in
the presence of the other rhesus alleles (rhA3GLL and rhA3GY).
Importantly, the observed activity of the different Vif proteins
against the rhA3G alleles mirrored the results obtained from
degradation experiments (compare Figure 5A and Figure 4).
In parallel, we analyzed the levels of encapsidated rhA3G in the
same virion preparations used for the infectivity assays, by
immunoblotting and densitometry (Figure 5B). In accordance
with the degradation and infectivity experiments, we observed
reduced incorporation of rhA3GLR in Vif-SIVmac239 comple-
mented virions relative to virions complemented with Vif-
SIVsmE041 (3.4-fold increase relative to p27) or Vif-SIVma-
c239(E17G) (4-fold increase relative to p27). Incorporation of
rhA3GY in the presence of any of the three Vif proteins was
essentially undetectable. Similar to the results of degradation
experiments (Figure 1B and Figure 3B), there were low but
detectable levels of rhA3GLL incorporation into Vif-SIVsmE041-
complemented and Vif-SIVmac239(E17G)-complemented virions,
and even very low levels of rhA3GLL incorporation into Vif-
SIVmac239 complemented virions. Thus, it is possible that
rhA3GLL also confers some resistance to Vif, albeit significantly
less than rhA3GLR.
Figure 4. The negatively charged glutamic acid at position 17 in the primate Vif protein allows for interaction with rhA3GLR. (A)
Immunoblot showing activity of Vif-SIVsmE041, Vif-SIVmac239, the mutants Vif-SIVmac239(E17G) and Vif-SIVmac239(R21K), and an empty vector (no
Vif) control against the three rhA3G alleles (rhA3GLR, rhA3GLL and rhA3GY). Anti-b-actin served as a protein loading control. (B) Immunoblot showing
activity of Vif-SIVsmE041 and Vif-SIVsmE543 and their mutants (Vif-SIVsmE041(G17E), Vif-SIVsmE543(E17)) as well as Vif-SIVmac239 and an empty
vector (no Vif) control against the three rhA3G alleles and a sooty mangabey A3G. Anti-b-actin served as a protein loading control.
doi:10.1371/journal.ppat.1003641.g004
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Discussion
New viral pathogens arise when viruses succeed in jumping
from natural reservoirs into new host populations, resulting in
emerging infectious diseases such as AIDS, SARS and pandemic
influenza [6,44,45,46]. The importance of ecological factors in
viral emergence is well documented, whereas the significance of
host genetic differences as barriers to emergence is still not clear
[47]. In particular, it is believed that cellular antiviral restriction
factors can act as blockades to cross-species transmission and viral
emergence, yet very few studies have examined this possibility in
vivo. The emergence of SIVmac and outbreaks of simian AIDS in
outbred colonies of macaques in the 1970s provides an unusual
opportunity to examine the impact of specific, host-encoded
restriction factors in the context of an emerging pathogen.
Focusing on SIVsm and SIVmac has multiple advantages for
understanding the genetics of lentiviral emergence: both the
natural reservoir host and the emergent new host are known (sooty
mangabeys and rhesus macaques, respectively); archived samples
and cloned, primary viral isolates are readily available; and most
importantly, several key host-encoded restriction factors that target
primate lentiviruses are known and have been well-characterized
at the molecular level [48,49,50,51].
Cellular restriction factors that target replication of primate
lentiviruses include A3G [17], TRIM5a [52], BST2/Tetherin
[53,54,55] and SAMHD1 [56,57]. Here, we demonstrate that
spread of SIVsm in rhesus macaques and emergence of pathogenic
SIVmac and simian AIDS required viral adaptation to overcome
restriction by rhesus macaque A3G. In particular, we found that
A3G is polymorphic in rhesus macaques, and that the most
frequent rhesus A3G alleles have complex substitutions in the N-
terminal domain (Y59/LR59–60 and Y59/LL59–60). We found that
Vif from SIVsm, a virus that jumped species at least twice (to
emerge as SIVmac in macaques and as HIV-2 in humans) does
not degrade the most common rhesus allele (rhA3GLR), whereas
SIVmac Vif degrades all three classes of rhesus alleles (rhA3GLR,
rhA3GLL and rhA3GY).
So far, two important determinants (amino acids 128 and 130)
in A3G have been shown to play a role in conferring species-
specific sensitivity to Vif [24,25,28,29,31,32,35] suggesting that
these residues might be part of a Vif-binding domain. At present,
there are no structural data for the N-terminal active domain of
A3G. To visualize how the rhesus 59Y/59LL60/59LR60 polymor-
phism might also affect interactions with Vif proteins, we modeled
the N-terminal sequence of rhA3G onto the recently published
human A3C crystal structure [58,59] (Figure 6). Unlike A3G, A3C
has only one active domain; however, both the sequence and
predicted secondary structure of A3C are similar to the N-terminal
active domain of A3G, such that the structure is a useful
approximation [60].
Using this hypothetical model of the N-terminal active site of
rhA3GLR, we compared the predicted positions of residues which
are known or thought to influence species-specific interactions of
A3G and Vif, including Arg60 (identified in this study), Lys128
[24,28] and Asp/Asn130 [32]. The model suggests that Arg60 and
Lys128 are probably located on the same face of A3G, within
approximately 20 A˚ of each other. Because variation at both sites
affects Vif-mediated degradation, the simplest explanation is that
residues 60 and 128 are part of a single Vif-binding surface on
A3G (this does not exclude the possibility that different Vif
homologs have evolved to make different contacts with the same
surface). Similarly, an insertion at position 64–66 in Colobinae A3G
(indicated in blue spheres in Figure 6) can also affect degradation
by Vif proteins of primate lentiviruses [32]. It would therefore
appear that these three documented determinants of species-
specific antiviral activity might occur on a single face of the A3G
Figure 5. Mutating the negatively charged glutamic acid at position 17 to glycine in Vif-SIVmac239 reduces infectivity and
increases incorporation of rhA3GLR into virions. (A) Shown is one representative of two independent infectivity assay experiments. Infectivity
was measured by titration on TZM-bl indicator cells. The virus was produced in HEK-293T/17 cells by co-transfection of a full-length SIVmac239DVif
plasmid, a plasmid coding for one of the three A3G alleles (rhA3GLR, rhA3GLL or rhA3GY) or a no A3G control and a plasmid coding for one of three Vif
proteins (Vif-SIVsmE041, Vif-SIVmac239 or Vif-SIVmac239(E17G)) or a no Vif, empty vector control. Error bars indicate the standard deviation of three
replicate infections. (B) Immunoblot was used to measure packaging of rhA3G into virions using virus preparations also used in the above infectivity
experiment. The amount of virus present is measured by detecting the SIV p27 core antigen with an anit-p27 antibody. The relative density of each
A3G band (as compared to the corresponding p27 band) is indicated below each lane.
doi:10.1371/journal.ppat.1003641.g005
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protein. This observation offers indirect but compelling evidence
that divergent lentiviral Vif proteins have exploited the same or
closely overlapping binding sites on primate A3G.
The adaptation of SIVmac to rhesus macaques included a
G17E substitution in Vif. Vif proteins from all SIVmac isolates
tested degraded rhA3GLR and all carried the G17E change,
including Vif from the independently derived SIVsmE543 - a clear
case of convergent evolution in a viral accessory protein. Our
results establish that interspecies variation in cellular restriction
factor A3G can pose a selective barrier to emergence of AIDS-
causing viruses, and just as adaptation of Vif contributed to the
emergence of pathogenic SIVmac, Vif plasticity could have
contributed to the modern distribution of simian immunodefi-
ciency viruses among their respective primate reservoirs.
The means by which SIVsm was initially transmitted to rhesus
macaques in US primate research centers is not known, although
indirect evidence suggests it was the unintentional result of
experimental exchange of infected material between the two
species in the 1960s or early 1970s [9]. Thus, the original
transmission event(s) may not recapitulate the kinds of mechanisms
that are thought to typically give rise to interhost transmission of
primate retroviruses in nature, such as biting, fighting with, or
preying on, viremic individuals. Nevertheless, replication of
primary isolates of SIVsmm in rhesus macaques is highly variable
and typically much lower relative to SIVmac isolates, such that the
emergence of SIVmac is very likely to have required adaptations
to overcome genetic divergence between the reservoir (sooty
mangabey) and spillover (rhesus macaque) hosts [15,61,62] Our
data indicate that adaptation to overcome restriction by a specific
subset of rhesus macaque A3G alleles played a key role in spread
of SIVsm in captive colonies of rhesus macaques, ultimately
contributing to its emergence as pathogenic SIVmac. At the time
of initial cross-species exposure, SIVsm was most likely sensitive to
rhA3G alleles with an LR at position 59/60 (and perhaps to a
lesser extent, alleles with an LL at position 59/60), but not to
alleles with a Y at position 59.
It is possible that animals bearing rhA3GY alleles served as
evolutionary ‘‘stepping-stones’’, by allowing for higher levels of
replication and higher probability of continued transmission and
spread of SIVsm in the captive rhesus macaque population. The
G17E mutation in Vif, whether it coincided with the initial cross-
species transmission or appeared subsequently, would have
allowed the virus to spread to a larger percentage of the macaque
population (e.g., those bearing restrictive A3GLR alleles), fostering
further adaptation to the new host.
It is tempting to speculate that the current frequency of
rhA3GLR alleles in U.S. macaque colonies was directly influenced
by the emergence of SIVmac and outbreaks of simian AIDS in the
1970s and early 1980s. However, the high frequency of rhA3GLR
in macaque colonies should also reflect the influence of founder
effects, depending on the initial frequency of the allele in the
founder populations that were used to establish and maintain
breeding colonies at the National Primate Research Centers
(NPRC). Because selective breeding programs are used to
intentionally maintain diversity in the NPRC colonies, deviations
from Hardy-Weinberg equilibrium cannot reliably be used to
estimate the relative contributions of selection and founder effects.
In order to study the possible influence of SIV emergence on host
Figure 6. Model of the N-terminal domain of rhesus APOBEC3G. A model of the N-terminal domain of rhA3GLR was generated using the
PHYRE2 server [59] using the A3C structure PDB: 3VOW as a model. (A) Position 60 is shown as a red sphere. A previously identified site of positive
selection and a determinant of species tropism, K128, is shown as a violet sphere. These two independent determinants of species tropism are
predicted to occur on the same face of the A3G N-terminal domain. The site of another previously identified polymorphism of rhesus macaques [32],
D/N130, is shown as a light green sphere. Indicated in blue is an insertion found in Colobinae monkeys [32]. Measurements using the predicted Ca
backbone indicate that these residues are within 20 A˚ of each other. Additional A3G polymorphisms identified in this study within rhesus macaques
(green spheres) or sooty mangabeys (orange spheres) are shown. (B) The same structure as in A, rotated by 270u around the Y-axis.
doi:10.1371/journal.ppat.1003641.g006
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A3G allele frequencies, it may be necessary to recover archived
genomic DNA samples from that era, if possible, and to compare
historical allele frequencies of captive macaques to allele frequen-
cies of wild macaques in Asia.
At least one study describes analysis of A3G polymorphism in a
cohort of SIV-infected macaques, and reports a weak, possible
association between rhA3G variation and viral replication [63].
Importantly, the virus in that retrospective study was SIVmac239,
a virus that is already well-adapted to the rhesus macaque host
(and has been used extensively as a model for preclinical AIDS
research for almost 30 years) [39,64,65,66,67]. Thus, the modest
correlation reported by Weiler et al. is consistent with our
observation that Vif-SIVmac can induce degradation of all three
allelic forms of rhA3G, and should be largely unaffected by the
A3G genotype.
We have also reported that variation in another restriction
factor, TRIM5, correlates with large differences in viremia in
rhesus macaques infected with SIVsmE543, and that TRIM5-
mediated suppression selects for emergence of resistant SIVsmm
variants [15]. As with A3G and SIVmac239, the impact of rhesus
TRIM5 on replication of established SIVmac isolates is minimal
[63,68]. Thus, our data and previously published studies of both
A3G and TRIM5 in macaques support the hypothesis that
restriction has its greatest biological impact as a modulator of
interspecies transmission and emergence of viral pathogens.
Evidence of positive selection in primate restriction factor loci
may therefore reflect recurrent or continuous lineage-specific
exposures to viruses of other species, with repeated transmission
events and outbreaks of disease driving fixation of resistance
alleles. This could occur in situations where different host
populations come into physical contact - for example, as the
result of fighting over territory or when one species routinely preys
on another. Whether restriction factors continue to play a role
after a pathogen becomes established in the new host is not as
clear, and will require further study.
Materials and Methods
Cell lines
Human Embryonic Kidney 293T/17 (HEK293T/17) cells
were obtained from American Type Culture Collection (Manassas,
VA). HeLa Human cervical carcinoma (TZM-bl) cells were
obtained through the NIH AIDS Reagent Program, Division
of AIDS, NIAID, NIH: TZM-bl from Dr. John C. Kappes,
Dr. Xiaoyun Wu and Tranzyme Inc. [69,70,71,72]. Both cell
lines were grown in Dulbecco’s modified Eagles medium
(DMEM) containing 10% fetal bovine serum (FBS) (Invitrogen;
Carlsbad, CA)
Immunoblotting
HEK293T/17 cells were seeded at a density of 66105 cells per
well in a 6-well plate or at 26106 in a 60 mm dish or a T25 flask.
Cells were co-transfected with appropriate amounts of the
indicated plasmids using either the GenJet transfection system
(SignaGen; Ijamsville, MD) or the Lipofectamine Plus reagent
(Invitrogen; Carlsbad, CA) following the manufacturer’s recom-
mendations and harvested 48–72 hours post transfection. Cells
were lysed in M-PER reagent (Pierce Biotechnology, Rockford, IL)
or Pierce IP-lysis Buffer (Thermo Fisher Scientific, Waltham, MA),
mixed with an equal volume of 26 laemmli sample buffer (Sigma,
St. Louis, MO) and solubilized by boiling for 10 min at 99uC.
Protein was separated by SDS/PAGE and tagged proteins were
detected with either mouse monoclonal anti-V5 antibody (Invitro-
gen; Carlsbad, CA) or mouse monoclonal anti-HA antibody
(Covance; Dedham, MA) using dilutions recommended by the
manufacturer. b-actin was detected with mouse monoclonal beta
actin-HRP antibody at a concentration of 1:1000 (Abcam Inc.,
Cambridge, MA). Virus was harvested by centrifugation (see
‘‘Encapsidation of Virus’’ section). Lysed, replication-competent
virus was detected with monoclonal SIVmac anti-p27 Antibody
(NIH AIDS Reagent Program) [73] at a dilution of 1:2000.
Co-immuno-precipitation
FLAG-tagged Vif expression plasmids (100 ng) were co-
transfected with HA-tagged A3G expression plasmid (900 ng)
and 1000 ng GST-expressing filler plasmid in 293T cells in a 6-
well format (2 mg DNA total). Cells were lysed two days post
transfection in a mild lysis buffer (0.5% triton X-100 in 16 PBS
supplemented with EDTA-free protease inhibitor cocktail, Roche)
on ice and the cell lysates were cleared by centrifuging at
14,0006g for 10 minutes at 4uC. Cleared lysates were incubated
with EZ-View anti-HA beads (Sigma) at 4uC for two hours. Beads
were washed 4 times in cold mild lysis buffer, followed by 4
additional washes in cold stringent lysis buffer (1% triton, 0.1%
SDS, 500 mM NaCl in PBS). Proteins were eluted from the beads
by boiling in LDS loading buffer (Sigma). Proteins were analyzed
by western blot for Vif (FLAG), A3G (HA) and tubulin.
Viruses
Full-length SIV viruses were produced in HEK293T/17 cells by
transfection using the GenJet transfection system (SignaGen;
Ijamsville, MD). SIVmac239DVif [74] plasmids were co-trans-
fected with 4 mg pcDNA3.1-Vif.HA (or and empty vector control)
and 3 mg pcDNA3.2-A3G.V5. Culture supernatants containing
virions were harvested three days post infection and used for
infectivity assays on TZM-Bl cells and for immunoblotting.
Infectivity assay
TZM-bl cells were seeded at a concentration of 16104 cells per
well in 96-well plates and infected with equal volumes of
replication-competent virus. Two independent experiments were
conducted, and all infections were performed in triplicate. Three
days post infection expression of luciferase was analyzed using the
Britelite Plus Ultra-High Sensitivity Luminescence Reporter Gene
Assay System (PerkinElmer Inc; Waltham, MA) and a Victor X5
Multilabel Plate Reader (PerkinElmer Inc; Waltham, MA). Results
were analyzed by one-way ANOVA and Tukey’s multiple
comparisons test, using PRISM 6.0b (GraphPad Software, Inc.,
La Jolla, CA.).
Plasmids
For the APOBEC3G clones, RNA was extracted from rhesus
macaque, sooty mangabey, African green monkey and pigtail
macaque B-cells and reverse transcribed to synthesize cDNA using
the one-step RT-PCR kit (Invitrogen; Carlsbad, CA) and cloned
into the pENTR directional TOPO cloning vector (Invitrogen;
Carlsbad, CA) according to manufacturer’s manual for further
sequence analysis. Sequences for independent rhesus macaque
alleles (rh1-rh6), sooty mangabey alleles (sm1-sm6) and one pigtail
allele (ptA3G) were submitted to Genbank (rh1-rh6: KF020481-
KF020486, sm1-sm6: KF020487- KF020492, ptA3G: KF169801).
For expression in mammalian cells, the protein coding fragments
were transferred into the pcDNA3.2/V5-DEST cloning vector
(Invitrogen, Carlsbad, CA) using the Gateway LR Clonase II
Enzyme Mix (Invitrogen, Carlsbad, CA).
For Vif-expressing plasmids, vif coding sequences were synthe-
sized (GeneArt) and cloned into pcDNA3.1 (Invitrogen, Carlsbad,
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CA) using PCR to add restriction sites 59HindIII and 39NotI as
well as adding a C-terminal HA-tag. Vif gene sequences used
can be found in GenBank: SIVmac (M33262), SIVsmE041
(HM059825), SIVmac142 (Y00277), SIVmne027 (U79412),
SIVmfa186 (KF030930), SIVsmE543 (U72748). The mutant
constructs were obtained by site-directed mutagenesis using
PfuTurbo Hotstart Polymerase (Agilent Technologies, Santa
Clara, CA) and were confirmed by sequence analysis.
Constructs for co-immunoprecipitation (rhA3GLR and rhA3GY)
were subcloned into ptr600 plasmids [75]. The A3G constructs
were C-terminally labeled with a 36HA tag by standard overlap
PCR. Vif-SIVmac239 and Vif-SIVsm were cloned into the pcrv
expression plasmid [76]. The Vif constructs were C-terminally
FLAG-tagged by standard overlap PCR. Correct cloned inserts
were confirmed by sequencing.
Sequencing of SIVmfa186 Vif
Retrospective analysis revealed that a pathogenic SIV was freely
circulating in crab-eating macaques (Macaca fascicularis) housed at
the New England Primate Research Center (NEPRC) [41]. An
isolate of this virus from animal MF186-76 was obtained from
frozen PBMCs, which were co-culture with H9 cells in 1987 [41].
A vial containing cell supernatants from this co-culture was
obtained (a gift from R.C. Desrosiers). Viral RNA was isolated
using a High Pure Viral RNA Kit (Roche USA, Indianapolis, IN).
Specific cDNA products corresponding to the Vif coding sequence
were amplified using the SuperScriptTM III One-Step RT-PCR
System with PlatinumH Taq High Fidelity kit (Invitrogen,
Carlsbad CA) using following the primers: 647-F AGGGGAG-
GAATAGGGGATATGACTC and SME041-envR1 R- CACT-
TAATAGCAAGAGCGCGATAAG. The PCR fragment was
then cloned using the TOPO TA cloning kit (Invitrogen:
Carlsbad, CA) and sequenced.
Genotyping
Rhesus macaque and sooty mangabey RNA samples were used
for initial screens for polymorphisms in APOBEC3G by RT-PCR
of the entire A3G coding sequence, cloning, and sequencing, as
described above (see section entitled ‘‘Plasmids’’). Additional,
allele-specific typing was performed by extraction of genomic
DNA followed by targeted PCR and direct sequencing. Specifi-
cally, APOBEC3G genotypes of rhesus macaques (Macaca mulatta)
and cynomolgus macaques (Macaca fascicularis) (also known as crab-
eating macaques) were determined by isolation of genomic DNA
from PBMCs using QIAamp DNA Blood Mini Kit (Qiagen;
Valencia, CA) and PCR using 100 ng gDNA, Taq polymerase
and primers (APOBEC3G-1aF: 59-GAG GAA AGG AGC TTC
AGT GGC AAG A-39, APOBEC3G-1aR: 59-GGA GGC CTC
AAG AGG GTA AGC AG-39) with following PCR conditions:
94uC – 1 min, 94uC – 15 sec, 59uC – 30 sec, 68uC – 1 min for a
total of 30 cycles, 68uC – 10 min) followed by direct sequencing of
a PCR fragment (APOBEC3G-1aF: 59-GAG GAA AGG AGC
TTC AGT GGC AAG A-39, APOBEC3G-1aR: 59-GGA GGC
CTC AAG AGG GTA AGC AG-39). PCR fragments were
sequenced by Retrogen (San Diego, CA) and data were analyzed
with the Codoncode software (Codoncode Corp; Dedham, MA).
Encapsidation of A3G
Two milliliters of the harvested virus-containing supernatants
were used to concentrate virus by ultracentrifugation through 20%
sucrose at 35,000 rpm for 75 min at 4uC. The virions were then
lysed with 100 ml 26 leammli sample buffer (Sigma, St. Louis,
MO) and boiled at 99uC for 10 min. Incorporated A3G and p27
was detected by an immunoblot assay.
Structure model
A model of the N-terminal active site of residues 1–195
of the rhA3GLR allele was geminated with high confidence
using the Protein Homology/analogy Recognition Engine V 2.0
server (PHYRE2) (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.
cgi?id = index) [59].
Accession numbers
Rhesus macaque alleles: rh1-rh6: KF020481- Rh6:KF020486
Sooty mangabey alleles: sm1-sm6: KF020487- KF020492
Pig tailed macaque: KF169801
Vif-SIVmfa186: KF030930
Supporting Information
Figure S1 Full alignment of rhA3G and smA3G alleles
identified in this study. The rhesus macaque alleles are
indicated with rh1-rh6, the sooty mangabey alleles are indicated
with sm1-sm6. The green arrows indicate the polymorphisms in
rhesus macaques, the orange arrows indicate polymorphisms in
sooty mangabey. The asterisk indicate differences between
species.
(TIF)
Figure S2 Incorporation and antiviral activity of rhesus
macaque and sooty mangabey APOBEC3G alleles.
Virions were produced in HEK-293T/17 cells by co-transfection
of a full-length SIVmac239DVif plasmid and a plasmid coding for
one of the six rhesus macaque or the six sooty mangabey alleles or
a no A3G control. Infectivity was measured by titration on TZM-
bl indicator cells. Error bars indicate the standard deviation of
three replicate infections. Immunoblot (bottom) was used to detect
incorporation of rhA3G or smA3G in pelleted virions. Virus
production was detected via the SIV p27 core antigen using an
anti-p27 monoclonal antibody. A3G incorporation into virions
was measured by using a V5 specific antibody.
(TIF)
Figure S3 All sooty mangabey alleles are degraded by
Vif-SIVsmE041 and Vif-SIVmac239. Sooty mangabey A3G
allele containing plasmids were co-transfected with a Vif-
SIVsmE041 or Vif-SIVmac239 containing plasmid or an empty
vector (no Vif) control. The ability of Vif-SIVsmE041 and Vif-
SIVmac239 to induce A3G degradation is shown. Anti-b-actin
served as a protein loading control.
(TIF)
Figure S4 A polymorphism in rhesus macaques at
position 130 influences the ability of the rhA3GLR allele
to resist Vif-SIVsmE041 induced degradation. (A) Site
directed mutagenesis was used to introduce a N130D mutation
into either one of the three rhA3G alleles (rhA3GLR, rhA3GLL or
rhA3GY). Their ability to resist Vif-mediated degradation was
visualized by western blot. We used an empty vector control to test
expression in the absence of Vif (indicated as ‘‘control’’). Anti-b-
actin served as a protein loading control. (B) Genotyping
frequencies of 130D/N (n = 219). (C) Frequencies of 130D and
130N among LR homozygotes.
(TIF)
Figure S5 Partial alignment of the NTD of Vif. Depicted is
an alignment of the first 56 amino acids of the viral Vif protein
from SIVs from different species. The sequences labeled with
accession numbers, including SIVsmCFU212, represent Vifs from
independently isolated SIVsm strains [42]. Highlighted in red is
residue 17, which is a negatively charged glutamic acid in most
APOBEC3G and Emergence of Pathogenic SIV
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macaque derived SIV strain Vifs and an uncharged glycine in Vif
proteins derived from HIV-2, SIVstm, SIVsmE041 and several
other SIVsm strains.
(TIF)
Figure S6 Other SIVsm isolates behave like Vif-
SIVsmE041. Immunoblot showing activity of Vif-SIVsmPBj,
Vif-SIVsm-PG, Vif-SIVsmCFU212 or an empty vector (no
Vif) control against the three rhA3G alleles (rhA3GLR, rhA3GLL
or rhA3GY). Anti-b-actin served as a protein loading control.
(TIF)
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